Thorsten Waloschek: 3D-Bioprinted Placentas Could Predict and Prevent Preeclampsia
Thorsten Waloschek, CEO at NeoPredics AG, shared a post on LinkedIn:
“Scientists in Sydney have 3D-bioprinted miniature placentas – a breakthrough that could transform how we understand pregnancy complications like preeclampsia.
Until now, studying the early placenta has been almost impossible. By the time a baby is born, the organ looks very different from its first-trimester state, and animal models don’t capture the unique biology of humans. Bioprinting changes that. Researchers can now grow organoids that closely mimic early placental tissue, expose them to stressors linked to preeclampsia, and even test potential therapies.
It is still early days, but this feels like a leap toward a future where complications in pregnancy could be predicted, prevented, or treated before they put lives at risk. Advances like this remind us how much innovation in bioengineering can ripple far beyond the lab, reshaping the health of generations to come.”
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 15:00Samantha Butts Shares Personal and Professional Insights in ASRM Close Up
-
Mar 21, 2026, 14:47Scammers Are Targeting ESHRE2026 Attendees – ESHRE
-
Mar 21, 2026, 14:26No Obvious Harm From Prolonged Oocyte Cryostorage – RBMO
-
Mar 21, 2026, 14:13Empowering Change: Health Systems at the Forefront of Ending FGM/C! – FIGO
-
Mar 21, 2026, 09:56Expanded Carrier Screening: Clinical, Ethical, and Psychosocial Perspectives from Ghent – ESHRE
-
Mar 21, 2026, 09:53Impact of Male Obesity on Embryo Development and Miscarriage Risk – Fertility and Sterility
-
Mar 20, 2026, 17:06Christopher Robinson: AJOG Expert Review on Placenta Accreta After Cesarean
-
Mar 20, 2026, 16:53HCG Failure and Trigger Strategies in IVF – Fertility Plus
-
Mar 20, 2026, 16:38Secure Your Early Bird Ticket for RCOG Annual Professional Development Conference – RCOG